Pancreatic Surgery and Risk Factors
The Risk Factors and Prognosis of Hyperglycemia Secondary to Pancreatic Surgery
1 other identifier
observational
382
0 countries
N/A
Brief Summary
The goal of this observational study is to learn about post-pancreatic surgery diabetes mellitus(PCRD).The main questions it aims to answer are:
- 1.What are the clinical characteristics of PCRD?
- 2.What are the related factors for PCRD? All patients with pancreatic surgery have been given standardized treatment fot the condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 2, 2024
CompletedFirst Posted
Study publicly available on registry
September 5, 2024
CompletedSeptember 19, 2024
September 1, 2024
7.6 years
September 2, 2024
September 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of glycaemic disorders(prevalence of diabetes) (postoperative fasting blood glucose/HbA1C)
The main objective of this study was the incidence of glucose metabolism disorders in patients treated with pancreatic surgery in our centre.
(within 5 years after surgery)
Secondary Outcomes (2)
overall survival
within 5 years after surgery
Disease-Free Survival
within 5 years after surgery
Interventions
patients who did pancreas-related surgery
Eligibility Criteria
patients treated with pancreatic surgery in our centre.
You may qualify if:
- \. Age ≥18 years and \<80 years, male or female; 2. Patients who underwent pancreatic resection in pancreaticobiliary surgery since January 2017 3. Those who have previously completed a cohort study in pancreaticobiliary surgery and signed informed consent; 4. Those who have completed and banked serum specimens and pathology specimens in our hospital.
You may not qualify if:
- \. Age \<18 years or ≥80 years; 2. Those with preoperative fasting blood glucose ≥5.8 mmol/l or HbA1c ≥6.0% or a history of diabetes; 3. Those with missing relevant data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Shanghai Changzheng Hospital
Study Record Dates
First Submitted
September 2, 2024
First Posted
September 5, 2024
Study Start
January 1, 2017
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share